Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3089 |
|
Actual shortage: | 248 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2817 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2024-01-05 | 2024-02-02 | 215212 |
APO-METOPROLOL | 25MG | TABLET | Resolved | 2024-01-05 | 2024-03-22 | 215233 |
APO-CARVEDILOL | 25MG | TABLET | Actual shortage | 2024-01-12 | 2024-01-12 | 215952 |
APO-AMPHETAMINE XR | 25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2024-01-12 | 2024-03-01 | 215964 |
APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2024-01-19 | 2024-04-05 | 216650 |
APO-QUETIAPINE FUMARATE | 25MG | TABLET (IMMEDIATE RELEASE) | Actual shortage | 2024-01-19 | 2024-02-23 | 216699 |
APO-PREGABALIN | 25MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-05-08 | 216732 |
ANAFRANIL | 25MG | TABLET | Resolved | 2024-03-15 | 2024-03-22 | 222473 |
APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2024-03-15 | 2024-05-03 | 222481 |
APO-SITAGLIPTIN MALATE | 25MG | TABLET | Resolved | 2024-04-12 | 2024-05-31 | 224977 |
APO-SITAGLIPTIN MALATE | 25MG | TABLET | Resolved | 2024-05-10 | 2024-05-31 | 227717 |
APO-HYDRALAZINE | 25MG | TABLET TABLET | Actual shortage | 2024-05-24 | 2024-05-24 | 228804 |
APO-ATOMOXETINE | 25MG | CAPSULE | Anticipated shortage | 2024-05-30 | 2024-05-30 | 229164 |
APO-TETRABENAZINE | 25MG | TABLET | Actual shortage | 2024-06-06 | 2024-06-06 | 229764 |
APO-SERTRALINE | 25MG | CAPSULE | Actual shortage | 2024-06-06 | 2024-06-06 | 229767 |
APO-NAPRO-NA | 275MG | TABLET | Resolved | 2018-05-15 | 2018-10-05 | 49499 |
APO-NAPRO-NA | 275MG | TABLET | Resolved | 2022-06-06 | 2022-08-22 | 162077 |
APO-METHYLPHENIDATE ER | 27MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-07-25 | 2017-11-03 | 16938 |
APO-METHYLPHENIDATE ER | 27MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-02-01 | 2018-05-24 | 37963 |
APO-METHYLPHENIDATE ER | 27MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-07-04 | 2018-08-01 | 54285 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60249 |
APO NAPROXEN TAB 125MG | 125MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60663 |
APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
APO-SULIN TAB 150MG | 150mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1186 |
APO-CLINDAMYCIN | 150MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-28 | 60396 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
ACID REDUCER | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71210 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
APO-CLINDAMYCIN | 150MG | CAPSULE | Discontinued | 2019-11-11 | 2019-11-11 | 98363 |
APO-OXAZEPAM | 15MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60678 |
APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
APO-PINDOL TAB 15MG | 15MG | TABLET | Discontinued | 2022-02-09 | 2022-12-09 | 154574 |
APO-SOTALOL | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |